Mounjaro®
Starting from £179.99/mo
Start journey Learn moreThe Mounjaro Quick Pen uses its own built-in needle that deploys automatically when you press the pen against your skin — there is no separate needle to attach or detach. Each pen contains four weekly doses and comes with a single, factory-fitted needle mechanism, so you do not need to source replacement needles for the Quick Pen itself. That said, understanding how the Quick Pen's needle system works, and how it differs from the Mounjaro 5 ml vial or other formats, matters for safe and comfortable injections. Mounjaro (tirzepatide) is a prescription-only medicine; a qualified prescriber assesses suitability before any treatment begins.
At your door the next working day.
Free, tracked, plain packaging.
BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.
Ten seconds. Private — nothing is stored or shared.
Your result updates live in the card alongside.
Your result
Your BMI is
—
which is in the healthy weight range
Start journeyBMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.
The problem
The nume way
clinician review. Free next working day delivery.
How it works
Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.
Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.
Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.
This is the question our prescribers hear most weeks from people switching to Mounjaro or moving between pen formats. The short answer: no. The Quick Pen's needle is integrated into the device from manufacture, which is one of the features that sets this format apart. When you press the pen firmly against the injection site (abdomen, thigh, or outer upper arm) the needle deploys, delivers the dose, and retracts automatically. The whole sequence takes a few seconds.
This is different from some other injectable medicines where you click on a fresh pen needle before each use. Because the Quick Pen's needle is pre-set and concealed, you never see it, which many people find far less intimidating than a conventional needle-and-pen setup. If the idea of injecting has been putting you off, that design detail is worth knowing.
What you will still need is a way to prepare the skin beforehand. Wiping the injection site with an alcohol swab before each dose is standard practice and removes surface bacteria that could cause site irritation. Let the skin dry fully before injecting. The NHS tirzepatide patient information page covers injection technique in accessible language and is worth a read alongside the Patient Information Leaflet supplied with your pen.
Even though the needle itself requires no maintenance on your part, where you inject absolutely does. Repeated injections into the same small area can cause lipohypertrophy, a localised thickening of fatty tissue that can affect how well the medicine is absorbed and leave a visible lump under the skin. Rotating sites systematically prevents this.
The three licensed injection sites for Mounjaro are the abdomen (avoiding the two-inch zone directly around the navel), the front or outer thigh, and the outer upper arm. Many people find it helpful to work around a mental clock: abdomen left, abdomen right, left thigh, right thigh, and so on. Keeping a quick note on your phone of where you last injected takes seconds and pays off over months of weekly dosing.
Injection comfort also depends on letting the pen reach room temperature before use. Injecting straight from the fridge can sting. Taking the pen out 20 to 30 minutes beforehand (while you are getting ready in the morning, for example) is usually enough. Full storage guidance is in the Patient Information Leaflet; for precise temperature windows, that leaflet is the definitive source, and our clinical team always defers readers there rather than repeating figures that could differ by batch.
For a full walkthrough of technique, the Mounjaro Quick Pen instructions page covers the step-by-step process in detail.
Because the Quick Pen's needle never visibly extends, it is easy to underestimate the disposal requirement. The needle is still there inside the used pen, and used pens must go into an approved sharps container, never the recycling bin, never a standard bin bag. An NHS sharps collection or a local pharmacy takeback scheme will accept a sealed sharps bin. If you are unsure what is available in your area, your GP surgery or local council website can point you to the nearest service.
A 1-litre sharps container holds a practical number of used Quick Pens and is the size most household users choose. Fill it to the marked line only; overfilled containers become a handling risk. Seal it, label it, and drop it at your collection point. That is the complete cycle, and getting into the habit early means it becomes automatic by the time you are a few months into treatment.
If you are comparing costs across providers before starting, the Mounjaro price comparison page sets out what the UK private market typically looks like and what legitimate treatment pricing should include.
Some injection-site reactions are expected: mild redness, a small raised area, or brief tenderness are common and usually settle within a day or two. Persistent swelling, pain that worsens rather than improves, or any sign of infection (heat, spreading redness, discharge) should be reported to your prescriber promptly rather than waited out.
If you are finding injections consistently painful or noticing tissue changes, tell your clinical team before your next dose. Technique adjustments or a change in injection site are often all that is needed, but that decision sits with the prescriber, not a troubleshooting guide. The Mounjaro injection guidance page gives broader context on what to expect across the injection experience.
Mounjaro is a prescription-only medicine, and the full Mounjaro overview explains the clinical pathway from eligibility through to ongoing clinical review. If you have not yet started treatment and want a clinician to assess whether Mounjaro is appropriate for you, you can start your free consultation with our GPhC-registered prescribers today.
The people
Superintendent Pharmacist (GPhC No. 2217101)
Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.
Clinical Lead (GPhC No. 2231744)
Sets our clinical standards and checks everything we publish against current MHRA guidance.
Independent Prescriber (GPhC No. 2084501)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.
Independent Prescriber (GPhC No. 2083426)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.